SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)

Amy D. Proal(Georgetown University), E. John Wherry(Parker Institute for Cancer Immunotherapy), Christopher L. Dupont(J. Craig Venter Institute), Akiko Iwasaki(Yale University), Brittany P. Boribong(Harvard University), David Putrino(Icahn School of Medicine at Mount Sinai), Mark M. Painter(Translational Therapeutics (United States)), Etheresia Pretorius(University of Liverpool), Lael M. Yonker(The University of Texas Southwestern Medical Center), Daniel S. Chertow(National Institute of Allergy and Infectious Diseases), Michael B. VanElzakker(Massachusetts General Hospital), Richard H. Scheuermann(Los Alamos National Laboratory), Gene S. Tan(J. Craig Venter Institute), Diane E. Griffin(Johns Hopkins University), Michela Locci(University of Pennsylvania), Soo Aleman(Karolinska University Hospital), Michael J. Peluso(San Francisco General Hospital), Alessio Fasano(Harvard University), Rudolph E. Tanzi(Harvard University), Saurabh Mehandru(Icahn School of Medicine at Mount Sinai), Sara Cherry(California University of Pennsylvania), Marcus Buggert(Karolinska University Hospital), Marcelo Freire(J. Craig Venter Institute), Steven G. Deeks(University of California, San Francisco), E. Wesley Ely(Vanderbilt University), Henry F. VanBrocklin(University of California, San Francisco), Linda N. Geng(Palo Alto University), Helen Davies(Cardiff and Vale University Health Board), David Izquierdo‐Garcia(Harvard University), David A. Price(University Hospital of Wales), William A. Eimer(Harvard University), Katie Bach(Brookings Institution), Timothy J. Henrich(University of California, San Francisco)
Nature Immunology
September 4, 2023
Cited by 281


Related Papers